Last reviewed · How we verify
Continues peripheral block — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Continues peripheral block (Continues peripheral block) — Assaf-Harofeh Medical Center.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Continues peripheral block TARGET | Continues peripheral block | Assaf-Harofeh Medical Center | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Continues peripheral block CI watch — RSS
- Continues peripheral block CI watch — Atom
- Continues peripheral block CI watch — JSON
- Continues peripheral block alone — RSS
Cite this brief
Drug Landscape (2026). Continues peripheral block — Competitive Intelligence Brief. https://druglandscape.com/ci/continues-peripheral-block. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab